N G Industries Ltd.
BSE: NGIND
Prev Close
138.55
Open Price
135.25
Volume
39
Today Low / High
135.25 / 144.55
52 WK Low / High
120.05 / 186.9
Range
137 - 152
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 144.55, reflecting a change of 6 (4.33057%). The expected target range on the BSE is 137 - 152. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
N G Industries Ltd. Graph
N G Industries Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for N G Industries Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 144.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 144.55 | 146.00 | 131.40 - 160.60 |
| 147.44 | 117.95 - 176.93 | ||
| 148.89 | 104.22 - 193.55 | ||
| Bearish Scenario | 144.55 | 143.10 | 128.79 - 157.41 |
| 141.66 | 113.33 - 169.99 | ||
| 140.21 | 98.15 - 182.28 |
Overview of N G Industries Ltd.
ISIN
INE825C01018
Industry
Medical - Care Facilities
Vol.Avg
1,002
Market Cap
497,884,300
Last Dividend
3.5
Official Website
IPO Date
2002-01-08
DCF Diff
89.96
DCF
59
Financial Ratios Every Investor Needs
Stock Dividend of NGIND
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-19 | September 19, 25 | 3.5 | 3.5 | 2025-09-20 | 2025-10-27 | |
| 2024-09-20 | September 20, 24 | 3.5 | 3.5 | 2024-09-21 | 2024-10-28 | |
| 2023-09-22 | September 22, 23 | 3.5 | 3.5 | 2023-09-23 | 2023-10-30 | |
| 2022-09-16 | September 16, 22 | 3.5 | 3.5 | 2022-09-17 | 2022-10-23 | |
| 2019-09-12 | September 12, 19 | 3.5 | 3.5 | 2019-09-13 | 2019-10-20 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 16.55 Cr | 7.07 Cr | 9.48 Cr | 0.5727 | 0.00 Cr | 0.04 Cr | 1.18 Cr | 7.74 Cr | 23.10 | 9.80 Cr | 0.4677 |
| 2024-03-31 | 16.88 Cr | 7.06 Cr | 9.82 Cr | 0.5816 | 0.00 Cr | 0.08 Cr | 9.73 Cr | 5.03 Cr | 15.02 | 6.52 Cr | 0.2982 |
| 2023-03-31 | 18.70 Cr | 6.84 Cr | 11.87 Cr | 0.6344 | 0.00 Cr | 5.05 Cr | 1.35 Cr | 8.32 Cr | 24.82 | 10.25 Cr | 0.4446 |
| 2022-03-31 | 18.42 Cr | 6.58 Cr | 11.84 Cr | 0.6430 | 0.00 Cr | 4.74 Cr | 1.79 Cr | 2.61 Cr | 7.79 | 3.99 Cr | 0.1416 |
| 2021-03-31 | 11.88 Cr | 3.21 Cr | 8.67 Cr | 0.7298 | 0.00 Cr | 3.79 Cr | 0.77 Cr | 0.61 Cr | 1.83 | 1.40 Cr | 0.0517 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.34 Cr | 41.62 Cr | 3.10 Cr | 38.5185 Cr | 1.78 Cr | -0.56 Cr | 0.75 Cr | 5.64 Cr | 0.00 Cr | 0.00 Cr | 31.73 Cr | 3.1040 Cr |
| 2024-03-31 | 2.35 Cr | 39.92 Cr | 3.79 Cr | 36.1357 Cr | 1.18 Cr | -1.17 Cr | 0.63 Cr | 5.62 Cr | 0.00 Cr | 0.00 Cr | 28.95 Cr | 3.7860 Cr |
| 2023-03-31 | 1.72 Cr | 30.72 Cr | 2.52 Cr | 28.2023 Cr | 0.59 Cr | -1.13 Cr | 0.65 Cr | 5.19 Cr | -0.11 Cr | 0.00 Cr | 22.27 Cr | 2.5174 Cr |
| 2022-03-31 | 1.39 Cr | 27.15 Cr | 3.24 Cr | 23.9111 Cr | 0.51 Cr | -0.87 Cr | 2.81 Cr | 5.55 Cr | 1.25 Cr | 0.00 Cr | 16.15 Cr | 3.2430 Cr |
| 2021-03-31 | 1.63 Cr | 17.05 Cr | 2.05 Cr | 15.0060 Cr | 0.27 Cr | -1.36 Cr | 0.57 Cr | 5.33 Cr | 0.00 Cr | 0.00 Cr | 8.16 Cr | 2.0452 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.7097 Cr | -2.1684 Cr | -0.5730 Cr | 2.0479 Cr | -0.0316 Cr | 2.3409 Cr | -0.6618 Cr | 7.7395 Cr | 0.5985 Cr | -1.1715 Cr | -0.1132 Cr |
| 2024-03-31 | -1.0199 Cr | 2.2480 Cr | -0.5986 Cr | -2.0688 Cr | 0.6295 Cr | 2.3725 Cr | -1.0489 Cr | 5.0337 Cr | 0.5913 Cr | -1.1739 Cr | 0.0161 Cr |
| 2023-03-31 | 3.1588 Cr | -1.7167 Cr | -1.1097 Cr | 2.9965 Cr | 0.3323 Cr | 1.7431 Cr | -0.1622 Cr | 9.6490 Cr | 0.0770 Cr | -1.1734 Cr | 2.1555 Cr |
| 2022-03-31 | -1.7275 Cr | 1.2553 Cr | 0.2227 Cr | -2.5185 Cr | -0.2495 Cr | 1.4107 Cr | -0.7910 Cr | 3.3187 Cr | 0.2437 Cr | -0.0054 Cr | -2.2321 Cr |
| 2021-03-31 | 1.3509 Cr | 1.9979 Cr | -2.7836 Cr | 0.7722 Cr | 0.5652 Cr | 1.6602 Cr | -0.5787 Cr | 0.8327 Cr | -2.7528 Cr | -0.0103 Cr | -0.0262 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 4.29 Cr | 1.92 Cr | 2.36 Cr | 0.5510 | 0.35 Cr | 0.42 Cr | 1.27 | 0.50 Cr | 0.0991 |
| 2025-09-30 | 4.05 Cr | 1.89 Cr | 2.15 Cr | 0.5326 | 0.18 Cr | 0.43 Cr | 1.28 | 0.75 Cr | 0.1056 |
| 2025-06-30 | 3.70 Cr | 0.90 Cr | 2.80 Cr | 0.7569 | 0.19 Cr | 0.19 Cr | 0.58 | 0.44 Cr | 0.0525 |
| 2025-03-31 | 4.47 Cr | 1.83 Cr | 2.64 Cr | 0.5910 | 0.38 Cr | -2.43 Cr | -7.26 | -2.64 Cr | -0.5447 |
| 2024-12-31 | 4.00 Cr | 1.08 Cr | 2.91 Cr | 0.7290 | 0.25 Cr | 6.71 Cr | 20.03 | 8.08 Cr | 1.6792 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.41 Cr | 0.00 Cr | 2.41 Cr | 0.71 Cr | 0.97 Cr | 4.10 Cr | 5.38 Cr | 43.02 Cr | 3.86 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -38.52 Cr |
| 2025-03-31 | 2.34 Cr | 0.21 Cr | 2.55 Cr | 0.74 Cr | 0.75 Cr | 4.04 Cr | 5.64 Cr | 41.62 Cr | 3.10 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 5.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -41.71 Cr |
| 2024-09-30 | 2.53 Cr | 2.95 Cr | 5.50 Cr | 0.27 Cr | 0.72 Cr | 6.65 Cr | 5.54 Cr | 48.44 Cr | 6.73 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -2.43 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 6.71 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 2.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,803.00 | ₹1,121,951,678,571.00 | ₹381,240.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,043.10 | ₹1,015,033,073,603.00 | ₹2,366,853.00 |
| Fortis Healthcare Limited | FORTIS | ₹881.80 | ₹665,722,094,906.00 | ₹867,525.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,750.50 | ₹355,526,261,168.00 | ₹315,853.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹665.50 | ₹344,021,264,708.00 | ₹341,357.00 |
| Global Health Limited | MEDANTA | ₹1,105.20 | ₹297,067,116,924.00 | ₹75,686.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹688.50 | ₹275,495,656,748.00 | ₹528,722.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,183.20 | ₹120,164,798,112.00 | ₹125,027.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,264.90 | ₹82,934,461,228.00 | ₹7,476.00 |
| HealthCare Global Enterprises Limited | HCG | ₹578.50 | ₹82,077,101,002.00 | ₹120,568.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹681.40 | ₹65,655,858,860.00 | ₹286,244.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹404.10 | ₹37,045,059,300.00 | ₹165,521.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹229.81 | ₹36,192,560,189.00 | ₹51,585.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: male
Year Born: 1963
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about N G Industries Ltd.
The CEO is Rajesh Goenka.
The current price is ₹148.60.
The range is ₹120.05-186.9.
The market capitalization is ₹49.79 crores.
The dividend yield is 2.36%.
The P/E ratio is -35.87.
The company operates in the Healthcare sector.
Overview of N G Industries Ltd. (ISIN: INE825C01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹49.79 crores and an average daily volume of 1,002 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹3.5.